The Online Investor

Slideshow Stock Splits

By The Online Investor Staff, updated Tue., Dec. 6, 8:38 AM

Slide #1. Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) 1 for 40 Reverse Split

Announced: 12/1/2022
Stock Split: 1 for 40
Record Date: 12/1/2022
Pay Date: 12/2/2022
ELOX Optionable?: Yes

Eloxx Pharmaceuticals is a clinical-stage biopharmaceutical company developing an oral small molecule ribosome modulating agents and eukaryotic ribosome selective glycosides (ERSGs) for the treatment of rare and ultra-rare premature stop codon diseases and ribosomal mutations. Co.'s TURBO-ZM™ platform is designed to enable synthesis of macrolides that can be supported to modulate the human, bacterial or viral ribosomes to treat rare diseases. ELX-02, an ERSG, is a small molecule drug candidate designed as an analogue to gentamicin and geneticin to restore production of functional proteins, and is in clinical development for the treatment of cystic fibrosis patients with nonsense mutations.
ELOX Detailed Information Page & Split History »

Company Name: 
Eloxx Pharmaceuticals Inc
Website: 
www.eloxxpharma.com
Sector: 
Drugs & Pharmaceuticals
Number of ETFs Holding ELOX: 
3
Total Market Value Held by ETFs: 
$1.11M

Open the ELOX Page at The Online Investor (in a new window) »

List of Stock Splits in this Slideshow: Ticker Stock Split Announced Record Date Pay Date Optionable MSGM 1 for 10 11/9/2022 11/9/2022 11/10/2022 No ALRN 1 for 20 11/10/2022 11/10/2022 11/11/2022 No KTRA 1 for 50 11/11/2022 11/11/2022 11/12/2022 No SNES 1 for 20 11/15/2022 11/15/2022 11/16/2022 No PALI 1 for 50 11/15/2022 11/15/2022 11/16/2022 No SDIV 1 for 3 11/18/2022 12/19/2022 12/20/2022 Yes SDEM 1 for 3 11/18/2022 12/19/2022 12/20/2022 Yes SRET 1 for 3 11/18/2022 12/19/2022 12/20/2022 Yes EDUT 1 for 3 11/18/2022 12/19/2022 12/20/2022 No CHIR 1 for 3 11/18/2022 12/19/2022 12/20/2022 Yes EWEB 1 for 3 11/18/2022 12/19/2022 12/20/2022 No BITS 1 for 4 11/18/2022 12/19/2022 12/20/2022 Yes BKCH 1 for 4 11/18/2022 12/19/2022 12/20/2022 Yes EBON 1 for 30 11/21/2022 11/21/2022 11/22/2022 Yes NRGD 1 for 10 11/21/2022 12/1/2022 12/2/2022 No OILD 1 for 10 11/21/2022 12/1/2022 12/2/2022 No QLGN 1 for 10 11/22/2022 11/22/2022 11/23/2022 Yes SPCB 1 for 10 11/23/2022 11/22/2022 11/23/2022 No ASTC 1 for 30 11/23/2022 12/2/2022 12/5/2022 No CNSP 1 for 30 11/28/2022 11/28/2022 11/29/2022 No DRRX 1 for 10 11/28/2022 12/5/2022 12/6/2022 Yes TUEM 1 for 30 11/29/2022 11/30/2022 12/1/2022 Yes PTPI 1 for 10 11/30/2022 11/30/2022 12/1/2022 Yes BXRX 1 for 40 11/30/2022 11/30/2022 12/1/2022 No ELOX 1 for 40 12/1/2022 12/1/2022 12/2/2022 Yes
Quotes delayed 20 minutes

Email EnvelopeFree ELOX Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Strong Buy (4.00 out of 4)
91st percentile
(ranked higher than approx. 91% of all stocks covered)

Analysts' Target Price:
ELOX Stock Forecast

Based on Zacks ABR data;
powered by Xignite

Stock Splits Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2022, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.